Consensus on resectability in N3 head and neck squamous cell carcinomas: GETTEC recommendations.

Date publication

avril 2020

Journal

Oral oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GALLET Patrice

Tous les auteurs :
Carsuzaa F, Gorphe P, Vergez S, Malard O, Fakhry N, Righini C, Philouze P, Lasne-Cardon A, Gallet P, Tonnerre D, Bozec A, de Mones E, Baujat B, Laccourreye L, Babin E, Dufour X, Thariat J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32335323

Résumé

Among patients with T0-2 N3 head and neck squamous cell carcinomas (HNSCC), those undergoing upfront neck dissection have better oncological outcomes. However, there is no consensual definition of disease resectability of N3 nodes, leading to major treatment attrition and interpretation biases between studies. We established a Delphi method-based consensus to define resectability and impact on decision-making for upfront neck dissection in N3 patients.

Mots clés

Cervical nodes, Chemoradiation, Contraindication, Head and neck squamous cell carcinoma, Neck dissection, Surgery

Référence

Oral Oncol.. 2020 Apr 23;106:104733